Cetrorelix Acetate Kit
Product Images NDC 67184-0605

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 67184-0605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cetrorelix 01)

Chemical structure diagram of Cetrorelix Acetate, the active ingredient in the product Cetrorelix Acetate for Injection. The diagram depicts the molecular arrangement including functional groups and bonds, along with an acetate (AcOH) component.*

FDA Label Image

Figure (Cetrorelix 02)

An instructional illustration depicting the proper technique for administering a subcutaneous injection. The image shows two hands pinching a fold of skin on the forearm to prepare for injection, highlighting an important step in subcutaneous drug administration.*

FDA Label Image

Figure (Cetrorelix 03)

Image of a Cetrorelix acetate injection kit by Qilu Pharmaceutical Co., Ltd. The kit includes a vial of Cetrorelix Acetate for Injection, a syringe, and two needles, designed for subcutaneous administration.*

FDA Label Image

Figure (Cetrorelix 04)

An instructional illustration showing two steps: first, twisting off the cap of a vial, and second, removing the rubber stopper of the vial by pulling it upward. This is likely part of the preparation instructions for Cetrorelix Acetate for Injection kit by Qilu Pharmaceutical Co., Ltd.*

FDA Label Image

Figure (Cetrorelix 05)

An instructional line drawing showing a hand holding a syringe and inserting the needle into a vial stopper. The image demonstrates the proper technique for withdrawing medication from the vial for injection use.*

FDA Label Image

Figure (Cetrorelix 06)

An instructional illustration showing a syringe drawing liquid from a vial, likely demonstrating the preparation of an injectable solution from the vial. The image is simple and monochrome, focusing on the vial and syringe interaction.*

FDA Label Image

Figure (Cetrorelix 07)

An instructional line drawing illustrating the preparation of a Cetrorelix acetate injection. It shows hands stabilizing a vial with one hand while using a syringe to withdraw medication from the vial with the other hand.*

FDA Label Image

Figure (Cetrorelix 08)

An instructional diagram showing the process of drawing up medication from a vial into a syringe. The image depicts a vial positioned above a syringe with an arrow indicating downward motion, illustrating medication transfer for subcutaneous injection.*

FDA Label Image

Figure (Cetrorelix 09)

An instructional illustration depicting a syringe with arrows indicating a rotational or turning motion, possibly demonstrating how to prepare or use the syringe associated with Cetrorelix acetate for injection subcutaneous kit.*

FDA Label Image

Figure (Cetrorelix 10)

An instructional diagram showing a syringe with a needle, highlighting the subcutaneous injection method by an arrow pointing to the injection site on the syringe. The image likely accompanies usage instructions for Cetrorelix Acetate for Injection.*

FDA Label Image

Figure (Cetrorelix 11)

An instructional illustration showing two panels: the left panel depicts a hand holding a syringe positioned near a woman's lower abdomen, indicating the subcutaneous injection site; the right panel shows a close-up of a hand administering a subcutaneous injection into the skin.*

FDA Label Image

Figure (Cetrorelix 12)

An instructional illustration showing a hand placing a syringe into a container labeled 'Biohazard.' The image likely demonstrates proper disposal of used syringes or sharps in a designated biohazard container.*

FDA Label Image

Principal Display Panel (Carton)

Cetrorelix Acetate for Injection 0.25 mg/vial packaging label for a subcutaneous injection kit by Qilu Pharmaceutical Co., Ltd. The carton contains one vial of lyophilized powder, one pre-filled syringe with diluent, a 20-gauge needle, and a 27-gauge needle. The label includes storage instructions to refrigerate at 2°C to 8°C and a barcode.*

FDA Label Image

Principal Display Panel (Tray kit)

Label for Cetrorelix Acetate for Injection 0.25 mg/vial kit. The label indicates a sterile product for subcutaneous use containing one vial of lyophilized powder, one pre-filled syringe with diluent, and needles. It is manufactured by Qilu Pharmaceutical Co., Ltd. and requires refrigerated storage at 2°C to 8°C (36°F to 46°F). An NDC code 67184-0605 is shown.*

FDA Label Image

Principal Display Panel (Vial)

Label for Cetrorelix Acetate for Injection 0.25 mg/vial, a sterile, single-dose vial for subcutaneous use. The label indicates storage refrigerated at 2°C to 8°C (36°F to 46°F) and protection from light. Manufactured by Qilu Pharmaceutical Co., Ltd., Jinan, China. Includes placeholders for lot number and expiration date.*

FDA Label Image

Principal Display Panel (Diluent Syringe)

Label for 1 mL Prefilled Sterile Water for Injection, USP manufactured by Qilu Pharmaceutical Co., Ltd., Jinan, China. The label includes NDC 67184-0568-1, lot number and expiration date placeholders, and indicates Rx only with a revision date of 1/2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.